DOCS (Doximity) EPS without NRI: $1.53 (TTM As of Mar. 2026)


DOCS Doximity Inc DOCS
82 GF Score
Price $20.83
GF Value $49.17
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Doximity EPS without NRI?

Doximity DOCS +1.71% 82 EPS without NRI is $1.53 as of Mar. 2026. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.17 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Doximity ranks better than 70.51% on this metric.

Doximity's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.26. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $1.53.

During the past 12 months, Doximity's average earnings per share (NRI) Growth Rate was 7.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 27.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 36.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Doximity's EPS without NRI or its related term are showing as below:

DOCS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 20.1   Med: 54.2   Max: 549
Current: 27.7

During the past 8 years, Doximity's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 549.00% per year. The lowest was 20.10% per year. And the median was 54.20% per year.

DOCS's 3-Year EPS without NRI Growth Rate is ranked better than
70.51% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11 vs DOCS: 27.70

Doximity's EPS (Diluted) for the three months ended in Mar. 2026 was $0.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.99.

Doximity's EPS (Basic) for the three months ended in Mar. 2026 was $0.10. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.04.


Doximity  (NYSE:DOCS) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Doximity EPS without NRI Related Terms


Doximity EPS without NRI Historical Data

* Premium members only.

The historical data trend for Doximity's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doximity EPS without NRI Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS without NRI
Get a 7-Day Free Trial 0.82 0.73 0.95 1.42 1.52

Doximity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.36 0.45 0.46 0.26

DOCS vs WAY, TXG, HNGE: EPS without NRI Comparison

For the Health Information Services subindustry, Doximity's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Doximity's PE Ratio without NRI falls into.


DOCS
82GF Score
Doximity Inc DOCS
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doximity EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $1.53 mean?
Doximity (DOCS) has a EPS without NRI of $1.53 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Doximity and its competitors. According to the industry distribution chart, Doximity ranks #151 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 29.5%.
Is Doximity's EPS without NRI too high?
Doximity's current EPS without NRI is $1.53. The Healthcare Providers & Services industry median EPS without NRI is 11.00. Doximity's value of $1.53 is 86.1% below this industry median. Based on the distribution chart, Doximity ranks #151 out of 512 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's EPS without NRI compare to WAY and TXG?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #151 out of 512 companies for EPS without NRI. This puts Doximity in the upper half of its industry. The industry median EPS without NRI is 11.00. Doximity's value of $1.53 is 86.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current EPS without NRI of $1.53 is 86.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current EPS without NRI is $1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.17, compared to a current price of $20.83 — trading 57.6% below its estimated fair value. The current EPS without NRI is $1.53 and 86.1% below the Healthcare Providers & Services industry median of 11.00. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Doximity (DOCS), the current EPS without NRI is $1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doximity (DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Doximity stock appears to be undervalued. The current stock price of $20.83 is trading 57.6% below its estimated GF Value™ of $49.17. GuruFocus considers Doximity to be Significantly Undervalued.

Key valuation signals for DOCS:

  • EPS without NRI: $1.53
  • GF Value™: $49.17 vs. price of $20.83 (57.6% below fair value)
  • GF Score™: 82/100 with 2 warning signs
  • Industry Position: 86.1% below the Healthcare Providers & Services median (#151 of 512)

No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Doximity Business Description

Other Exchanges D2OC34:Brazil
Address 500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score

Get the complete analysis for DOCS

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.83
Price
$49.17
GF Value